Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 Grant US-11840571-B2 United States of America 12 Dec 2023
Multi-chain polypeptide-containing tri-specific binding molecules Grant US-11820818-B2 United States of America 21 Nov 2023
Bispecific CD16-binding molecules and their use in the treatment of disease Grant US-11795226-B2 United States of America 24 Oct 2023
Tri-specific binding molecules that specifically bind to multiple cancer antigens Grant US-11697684-B2 United States of America 11 Jul 2023
Variant CD3-binding domains and their use in combination therapies for the treatment of… Grant US-11685781-B2 United States of America 27 Jun 2023
PD-1-binding molecules and methods of use thereof Grant US-11623959-B2 United States of America 11 Apr 2023
ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS Application WO-2022109498-A1 World Intellectual Property Organisation (WIPO) 27 May 2022
TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13Rα2 POSITIVE… Application WO-2021154543-A2 World Intellectual Property Organisation (WIPO) 05 Aug 2021
Multi-chain polypeptide-containing tri-specific binding molecules Grant US-10647768-B2 United States of America 12 May 2020
Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind… Grant US-10633440-B2 United States of America 28 Apr 2020
PD-1-binding molecules and methods of use thereof Grant US-10577422-B2 United States of America 03 Mar 2020
PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF Application EP-3456346-A1 European Patent Office 20 Mar 2019
COMBINATION THERAPY Application WO-2017214092-A1 World Intellectual Property Organisation (WIPO) 14 Dec 2017
CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2 Application WO-2016123143-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2016